Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...
CytoNiche Biotechnology, a biotechnology company with a cutting-edge of 3D dissolvable porous microcarriers, has officia...
A Hong Kong Baptist University (HKBU) collaborative research team has shown that urine tests for human cytomegalovirus (...
US-based Bionik Laboratories Corp. has entered into a distribution agreement with Pro-Med Technology, a provider of...
How is comprehensive genomic profiling (CGP) enhancing the quality of cancer management? Comprehensive genomic prof...
Hasten Biopharmaceutic has acquired the commercial rights in China for Rocephin, a long-acting, broad spectrum ceph...
Australian startup Cartherics has granted Shunxi Holding Group Co. a licence to develop, manufacture and commercialise C...
OBiO Technology (Shanghai) Corp., a leading gene and cell therapy contract development and manufacturing organisation (C...
Everest Medicines, China-based biopharmaceutical startup focused on the development, manufacturing and commercialisation...
ImmVira, a biotech startup based in China, has announced the appointment of Dr Oliver Kong as Chief Medical Officer...
Agilis Robotics, an innovative spin-off company from The University of Hong Kong, is making waves in the realm of endosc...
CBC Group, Asia's largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic, h...
China-based startup Chamlion has completed the B round fundraising of 236 million yuan (¥). This round of fundr...
Singapore-based OUE Lippo Healthcare has entered into a service agreement with the Chinese University of Hong Kong...
Hong Kong-based Essex Bio-Technology has announced that its wholly-owned subsidiary, Majeton has entered into an exclusi...
The MetaSight G200 is a groundbreaking karyotyping system launched by China-based startup Hangzhou Diagens Biotechnology...
Title: Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk Date: May 24, 2023 Synopsis ...
